RT @profshanecrotty: Our new paper rapidly studied T cell + antibody immune responses in average COVID-19 cases. This is good news in multi…
https://t.co/O8K6v3Cq9Z This is incredibly dense and I don’t know whether I will have the energy/intelligence to finish it but in the summary: 1/2 @profshanecrotty
RT @profshanecrotty: Our new paper rapidly studied T cell + antibody immune responses in average COVID-19 cases. This is good news in multi…
RT @profshanecrotty: Our new paper rapidly studied T cell + antibody immune responses in average COVID-19 cases. This is good news in multi…
No temais, tus células están alli: https://t.co/Ah9fGybnf5 https://t.co/dvByCDueS8
RT @profshanecrotty: Our new paper rapidly studied T cell + antibody immune responses in average COVID-19 cases. This is good news in multi…
RT @bryangrahn: @Scaramo07033006 @DiseaseEcology @EpiEllie @nataliexdean @aetiology @cmyeaton @MLevitt_NP2013 A couple of links on #2, incl…
@Scaramo07033006 @DiseaseEcology @EpiEllie @nataliexdean @aetiology @cmyeaton @MLevitt_NP2013 A couple of links on #2, including a Dr. Fauci shout out yesterday at the end: #covid19 https://t.co/HrX3zVGOCa https://t.co/5hvzfbNUfI https://t.co/8a0Ss6u3
RT @MenePangalos: Great paper for anyone interested in the immune response to SARS-CoV2- highlights the importance of not just neut antibod…
Great paper for anyone interested in the immune response to SARS-CoV2- highlights the importance of not just neut antibodies but also T cell responses
@ms_arg @rquiroga777 Todos los años circulan distintas cepas de coronavirus. Hasta tal punto que hay estudios que están mostrando que el 50% tiene immunidad contra Covid-19 sin hacer estado nunca expuesto previamente. https://t.co/y08zVJS3YO https://t.co/U
RT @profshanecrotty: Our new paper rapidly studied T cell + antibody immune responses in average COVID-19 cases. This is good news in multi…
Buenas noticias en el desarrollo de la vacuna con los antígenos que se están usando (S protein). https://t.co/qBYKBfNuZh https://t.co/2W0l8q5z6b
35% here, compared to 40%–60% in a previous study... "Importantly, we detected SARS-CoV-2-reactive CD4+ T cells in ∼40%–60% of unexposed individuals, suggesting cross-reactive T cell recognition" https://t.co/djhiWcLX14
RT @profshanecrotty: Our new paper rapidly studied T cell + antibody immune responses in average COVID-19 cases. This is good news in multi…
RT @profshanecrotty: Our new paper rapidly studied T cell + antibody immune responses in average COVID-19 cases. This is good news in multi…
@12FreeBeer Re: "This is the paper on substantial (~35%) TCell preexisting immunity" *Stop* misinforming people. https://t.co/8zDpdRPfjB https://t.co/iLpE7GTwEr https://t.co/BVrgs7M2RC
@12FreeBeer @NahasNewman Re: "for this virus which smart immunologists" Don't bring immunologists into it. Many of us don't have much patience for politically-motivated mis-informers like you. https://t.co/8zDpdRPfjB https://t.co/iLpE7GTwEr https://t.c
RT @DraganaObrado20: #Tcells & $Bcells & #COVID19 #Fauci https://t.co/g2gu0zaTqr
RT @profshanecrotty: Our new paper rapidly studied T cell + antibody immune responses in average COVID-19 cases. This is good news in multi…
Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals: Cell https://t.co/xhbaVWd3gb
RT @profshanecrotty: Our new paper rapidly studied T cell + antibody immune responses in average COVID-19 cases. This is good news in multi…
RT @profshanecrotty: Our new paper rapidly studied T cell + antibody immune responses in average COVID-19 cases. This is good news in multi…
RT @profshanecrotty: Our new paper rapidly studied T cell + antibody immune responses in average COVID-19 cases. This is good news in multi…
RT @profshanecrotty: Our new paper rapidly studied T cell + antibody immune responses in average COVID-19 cases. This is good news in multi…
RT @profshanecrotty: Our new paper rapidly studied T cell + antibody immune responses in average COVID-19 cases. This is good news in multi…
Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals Grifoni et al., 2020, Cell 181, 1489–1501 June 25, 2020 ª 2020 Elsevier Inc. https://t.co/6PjUnt6L2y Pioneers in T cell response to #SARSCoV2 P
RT @profshanecrotty: Our new paper rapidly studied T cell + antibody immune responses in average COVID-19 cases. This is good news in multi…
RT @profshanecrotty: Our new paper rapidly studied T cell + antibody immune responses in average COVID-19 cases. This is good news in multi…
RT @profshanecrotty: Our new paper rapidly studied T cell + antibody immune responses in average COVID-19 cases. This is good news in multi…
RT @Chino780: @EmBerk19 @BonesZk @rrashton @Tony__Heller @JenniferJJacobs There is evidence that people are producing T Cell responses natu…
RT @profshanecrotty: Our new paper rapidly studied T cell + antibody immune responses in average COVID-19 cases. This is good news in multi…
RT @profshanecrotty: Our new paper rapidly studied T cell + antibody immune responses in average COVID-19 cases. This is good news in multi…
RT @_renzomusic: if you guys wanted to read it, here’s the link: https://t.co/ikXVELmVyt
RT @profshanecrotty: Our new paper rapidly studied T cell + antibody immune responses in average COVID-19 cases. This is good news in multi…
RT @profshanecrotty: Our new paper rapidly studied T cell + antibody immune responses in average COVID-19 cases. This is good news in multi…
@IfedayoTiffy , cross reactive stories...
RT @profshanecrotty: Our new paper rapidly studied T cell + antibody immune responses in average COVID-19 cases. This is good news in multi…
RT @profshanecrotty: Our new paper rapidly studied T cell + antibody immune responses in average COVID-19 cases. This is good news in multi…
RT @DraganaObrado20: #Tcells & $Bcells & #COVID19 #Fauci
@oatila Já havia sido publicado, não? https://t.co/AqMYSqZtY9
RT @profshanecrotty: Our new paper rapidly studied T cell + antibody immune responses in average COVID-19 cases. This is good news in multi…
RT @profshanecrotty: Our new paper rapidly studied T cell + antibody immune responses in average COVID-19 cases. This is good news in multi…
Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with C... https://t.co/HRYrAuLaDH
A veey nice and important study 👍👍
RT @profshanecrotty: Our new paper rapidly studied T cell + antibody immune responses in average COVID-19 cases. This is good news in multi…
RT @ljiresearch: NIAID's Dr. Fauci shared @ljiresearch #COVID19 findings with Congress today. Read this study on how immune cells target #S…
RT @profshanecrotty: Our new paper rapidly studied T cell + antibody immune responses in average COVID-19 cases. This is good news in multi…
RT @ljiresearch: NIAID's Dr. Fauci shared @ljiresearch #COVID19 findings with Congress today. Read this study on how immune cells target #S…
RT @profshanecrotty: Our new paper rapidly studied T cell + antibody immune responses in average COVID-19 cases. This is good news in multi…
NIAID's Dr. Fauci shared @ljiresearch #COVID19 findings with Congress today. Read this study on how immune cells target #SARSCoV2: https://t.co/PAFMHi0dGP #coronavirus @CellCellPress @CellPressNews
RT @profshanecrotty: Our new paper rapidly studied T cell + antibody immune responses in average COVID-19 cases. This is good news in multi…
RT @profshanecrotty: Our new paper rapidly studied T cell + antibody immune responses in average COVID-19 cases. This is good news in multi…
@Yosenapar T細胞の交差反応性に関する興味深い論文を見つけました。 Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals https://t.co/fkZQSiSO8Y (日本語訳 by COVID19医療翻訳チーム) https://t.co/56jquTN4lA
#SquadGoals is one day having #DrFauci testify in congressional hearing and raise a #manuscript I have worked on! Here is the @CellPressNews #manuscript on #Tcells: https://t.co/PuvK6PCSBQ
Patients unexposed to SARS-CoV-2 show a T-Cell response to it! Previous exposure to OTHER coronaviruses maybe, could, might, afford some protection to the virus responsible to Covid-19. https://t.co/f7yoJtGq9W
@wszczeklik Ale to wiadomo od połowy maja co najmniej. Importantly, we detected SARS-CoV-2-reactive CD4+ T cells in ∼40%–60% of unexposed individuals, suggesting cross-reactive T cell recognition between circulating “common cold” coronaviruses and SARS-Co
RT @HenrikWallin3: @Incorparated2 @Ericson_ubbhult De som blir sjuka utvecklar antikroppar, men de som har kors-immunitet via t-celler ifrå…
RT @LouPalumbo: Links to studies showing up to 50% of the population w/ built in t-cell immunity against #covid19 Oxford 7/16 https://t.co…
@AaronErickson Although there's some evidence of limited cross-protection against SARS-CoV-2 spike protein in unexposed individuals, however not to the extent of other, more conserved viral antigens: https://t.co/hmbeZ7zgEq
@SusiAnsujali @KirstenThommes @Karl_Lauterbach oder sowas: oder sowas ... https://t.co/8Q8pyanr2a
RT @SantiagoTena: @pmarsupia Se prepublicó el 7 de mayo otro estudio que arrojaba similar conclusión en California, donde mas de un 30% de…
@pmarsupia Se prepublicó el 7 de mayo otro estudio que arrojaba similar conclusión en California, donde mas de un 30% de individuos sanos no infectados mostraban inmunidad cruzada con sars-cov-2, debida a coronavirus de resfriado https://t.co/ijIvjKQnfA
RT @EricTopol: The healthy people SARSCoV2 seronegative and their T cell reactive response (RHD) to the 4 common cold coronaviruses (from s…
RT @madelpozo67: Gracias Alberto. En línea con artículos previos, como el pionero de Crotty y Sette https://t.co/uSMla1GuCV o https://t.co/…
RT @madelpozo67: Estos 2 datos (% significativo de reactividad cruzada -y posible protección- x infecciones previas x otros coronavirus y a…
RT @madelpozo67: Gracias Alberto. En línea con artículos previos, como el pionero de Crotty y Sette https://t.co/uSMla1GuCV o https://t.co/…
RT @madelpozo67: Estos 2 datos (% significativo de reactividad cruzada -y posible protección- x infecciones previas x otros coronavirus y a…
RT @EricTopol: The healthy people SARSCoV2 seronegative and their T cell reactive response (RHD) to the 4 common cold coronaviruses (from s…
3 different papers now show uninfected healthy donors have T cells that respond to SARS COV-2. @cellcellpress https://t.co/XWclwa0cCy (Figure 2A); @nature https://t.co/iZNDAANwFU (Figure 4A); @nature https://t.co/nAeMuSndip (Figure 2D/E) #Immunity
Estos 2 datos (% significativo de reactividad cruzada -y posible protección- x infecciones previas x otros coronavirus y ausencia de anticuerpos) son aportaciones valiosas de este artículo, en línea con https://t.co/hdLj7g7b28 y la hipótesis q presenté en
Gracias Alberto. En línea con artículos previos, como el pionero de Crotty y Sette https://t.co/uSMla1GuCV o https://t.co/OTp6WbxJog ... Reforzando q la inmunidad celular puede ser la clave frente al SARS-CoV-2 Importante comprobar si es protectora y esti
RT @EricTopol: The healthy people SARSCoV2 seronegative and their T cell reactive response (RHD) to the 4 common cold coronaviruses (from s…
RT @EricTopol: The healthy people SARSCoV2 seronegative and their T cell reactive response (RHD) to the 4 common cold coronaviruses (from s…
@ImVickiOK @DOZER189 @0hi0an0n @OHdeptofhealth @CuyahogaCounty @PBS It's far lower with T Cell immunity. Reasonably estimates are 10-20% HIT. Even some mainstream media sources are catching on (3rd link below): https://t.co/pHLMwWPeZp https://t.co/oSWwmb
RT @EricTopol: The healthy people SARSCoV2 seronegative and their T cell reactive response (RHD) to the 4 common cold coronaviruses (from s…
RT @EricTopol: The healthy people SARSCoV2 seronegative and their T cell reactive response (RHD) to the 4 common cold coronaviruses (from s…
RT @EricTopol: The healthy people SARSCoV2 seronegative and their T cell reactive response (RHD) to the 4 common cold coronaviruses (from s…
RT @EricTopol: The healthy people SARSCoV2 seronegative and their T cell reactive response (RHD) to the 4 common cold coronaviruses (from s…